results publication for quarter/ half year ended 30.09.2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Beryl Drugs Ltd has informed the Bombay Stock Exchange that it published its unaudited financial results for the quarter ended 30 September 2025 (Q2 FY26) in two newspapers on 15 November 2025. The results appeared in Free Press (English edition) and Choutha Sansar (Hindi edition). The filing was made as required under SEBI Listing Regulations, 2015. The letter is signed by Managing Director Sanjay Sethi. This is a routine compliance disclosure — no actual revenue, profit, or other financial numbers are included in this particular filing.
No direct impact on shareholders — this is a standard regulatory disclosure confirming that the company's Q2 FY26 results were published in newspapers as mandated. Investors should look for the actual results document for any meaningful financial details.